Revista de Odontologia da UNESP
https://revodontolunesp.com.br/article/588018a67f8c9d0a098b4d53
Revista de Odontologia da UNESP
Original Article

Lesão central de células gigantes agressiva: relato de caso e revisão dos aspectos atuais

Downloads: 10
Views: 1652
A lesão central de células gigantes (LCCG) é considerada uma lesão rara de natureza proliferativa, de etiologia e patogenia desconhecidas. Ocorre mais em região de mandíbula e no gênero feminino. Este artigo relata um caso de LCCG em uma paciente do gênero feminino, 30 anos, melanoderma, e aborda aspectos atuais desta lesão, no tocante ao comportamento clínico, etiopatogenia e tratamento.
Lesão de células gigantes, mandíbula, central
The central giant cell granuloma (CGCG) is regarded as a rare proliferative lesion of unknown etiology and pathogenesis. It occurs frequently in the jaw region and in females. This article reports a case of CGCG in a female patient, 30 years-old, black and addresses current aspects of this lesion with regard to clinical behavior, pathogenesis and treatment.
Central giant cell granuloma, mandible, central


1. Lange J, Hans AVDP, Henk BVDH. Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:603-15.

2. Ünal M, Karabacak T, Vayisoglu Y, Bagis HE, Pata YS, Akbas Y. Central giant cell reparative granuloma of the mandible caused by a molar tooth extaction: Special reference to the manuever of drilling the surgical field. Int J Pediatr Otorhinolaryngol. 2006;70:745-8.

3. Vered M, Shohat I, Buchner A, Dayan D, Taicher S. Calcitonin nasal spray for treatment of central giant cell granuloma: clinical, radiological, and histological findings and immunohistochemical expression of calcitonin and glucocorticoid receptors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:226-39.

4. Cossío PI, de Fuentes RM, Carranza AC, Lagares DT, Pérez JLG. Recurrent central giant cell granuloma in the mandible: Surgical treatment and dental implant restoration. Med Oral Patol Oral Cir Bucal. 2007;12:E229-E232.

5. Souza PEA, Mesquita RA, Gomez RS. Evaluation of p53, PCNA, Ki-67, MDM2 and AgNOR in oral peripheral and central giant cell lesions. Oral Dis. 2000;6:35-9.

6. Sholapurkar AA, Pai KM, Ahsan A. Central giant cell granuloma of the anterior maxilla. Ind J Dent Res. 2008;19(1):78-82.

7. Bataineb AB, Al-Khateeb T, Rawashdeb MA. The surgical treatment of central giant cell granuloma of the mandible. J Oral Maxillofac Surg. 2002;60:756-61.

8. Souza PEA, Paim JFO, Carvalhais JN, Gomez RS. Immunohistochemical expression of p53, MDM2, Ki-67 and PCNA in central giant cell granuloma and giant cell tumor. J Oral Pathol Med. 1999;28:54-8.

9. Buresh CJ, Seemayer TA, Nelson M, Neff JR, Dorfman HD, Bridge J. t(X; 4) (q22; q131. 3) in giant cell reparative granuloma. Cancer Genet Cytogenet. 1999;115:80-1.

10. Aragão MS, Piva MR, Nonaka CFW, Freitas RA, Souza LB, Pinto LP. Central giant cell granuloma of the jaws and giant cell tumor of long bones – an immunohistochemical comparative study. J Appl Oral Sci. 2007;15:310-6.

11. Dewar AL, Farrugia AN, Condina MR, Bik TL, Hughes TP, Vernon-Roberts B, et al. Imatinib as a potential antiresorptive therapy for bone disease. Blood. 2006;107:4334-7.
588018a67f8c9d0a098b4d53 rou Articles
Links & Downloads

Rev. odontol. UNESP

Share this page
Page Sections